http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018362531-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b72407b3b3c5c6263f9038595efc0008 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2018-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_585024470746245204b15ac97f3bffc7 |
publicationDate | 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2018362531-A1 |
titleOfInvention | Novel kynureinine pathway inhibitors |
abstract | The present disclosure provides novel compounds capable of functioning as inhibitors of the kynurenine pathway and kits. |
priorityDate | 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 316.